Business Model Overview

  • For-profit research institute targeting regenerative medicine and focusing on development of stem-cell research derived products, techniques, apparatus, and related technological advancements, many of which have been pioneered by founding members
  • Treatments and products will be focused on enhancing the quality of life of patients stricken with chronic diseases entering the end stages of their ailments
  • Structured to follow the pharmaceutical business model
    • – Enormously successful, profit-driven model
    • – Not dependent on the constant need for grant money, publishing, and circumvents current bureaucratic quagmire
    • – Withstanding the test of time through a variety of difficult economic and regulatory environments
  • Focus will be on establishing new standards of care utilizing the break-through products and technologies pioneered by the company
  • Targeting to pursue 8 different product lines to diversify business risks and maximize profit opportunities